Yeung P K, Hubbard J W, Cooper J K, Midha K K
J Pharmacol Exp Ther. 1983 Sep;226(3):833-8.
Antibody specific for chlorpromazine sulfoxide (CPZSO) was produced in rabbits immunized with a hapten-bovine serum albumin conjugate, which was prepared by linking the 10-alkyl side chain of CPZSO to the protein molecule via a 2-carbon bridge. A simple radioimmunoassay was developed which can measure less then 20 pg of CPZSO in plasma. The assay has adequate specificity so that isolation of CPZSO is unnecessary. It was used together with a previously developed chlorpromazine (CPZ) radioimmunoassay to determine the concentrations of CPZ and CPZSO in plasma samples from five healthy volunteers after they had received a single 50-mg oral dose of CPZ. The plasma level data reported here support the previous findings that a significant portion of CPZ is metabolized to CPZSO during presystemic absorption. There are, however, differences to those previously reported in the plasma concentration ratios of CPZSO to CPZ. The possible reasons for these differences are discussed.
用半抗原 - 牛血清白蛋白偶联物免疫家兔制备了对氯丙嗪亚砜(CPZSO)具有特异性的抗体,该偶联物是通过一个二碳桥将CPZSO的10 - 烷基侧链连接到蛋白质分子上制成的。开发了一种简单的放射免疫分析法,该方法能够检测血浆中低于20 pg的CPZSO。该分析方法具有足够的特异性,因此无需分离CPZSO。它与先前开发的氯丙嗪(CPZ)放射免疫分析法一起用于测定五名健康志愿者口服50 mg单次剂量CPZ后血浆样本中CPZ和CPZSO的浓度。此处报告的血浆水平数据支持了先前的研究结果,即在首过吸收过程中,很大一部分CPZ代谢为CPZSO。然而,与先前报道的CPZSO与CPZ的血浆浓度比存在差异。讨论了这些差异的可能原因。